Navigation Links
Tailored Therapy May Help More Stop Smoking

People who metabolize nicotine slowly may need to wear nicotine patch longer, researchers say

TUESDAY, April 20 (HealthDay News) -- New research suggests that a set length of time for using the nicotine patch may not work for all smokers trying to kick the habit.

Researchers at the University of Pennsylvania School of Medicine have already discovered that some people -- about three-quarters of smokers -- break down (metabolize) nicotine more quickly from the patches than other people do. These people may do better by taking drugs like bupropion (Zyban).

And in the new study, researchers found that people who metabolized nicotine slowly did better if they used the nicotine patch for six months compared to slow metabolizers who were placed on the patch for only two months, followed by six months on a placebo (dummy) patch.

After six months there was no difference between the two groups.

While extended therapy helps people stay off tobacco and recover from lapses, "it only works as long as people are on it," noted Caryn Lerman, deputy director of the Abramson Cancer Center at the University of Pennsylvania, in a press release. "Those data lead to the compelling question of whether some smokers should be on nicotine patch therapy for the long term."

She said some patients may need to take treatment longer than the current recommended standard of two months.

The study is scheduled for release Tuesday at the American Association of Cancer Research's annual meeting in Washington D.C.

More information

The U.S. National Library of Medicine has more about quitting smoking.

-- Randy Dotinga

SOURCE: University of Pennsylvania School of Medicine, press release, April 20, 2010.

Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Targeted therapy prolongs life in patients with HER2-positive breast cancer
2. PharmMD Secures Investments to Fund New Opportunities in Medication Therapy Management
3. More smokers kick the habit with extended nicotine patch therapy, Penn research shows
4. Experts Issue Warning on Prostate Hormone Therapy
5. ASGCT: Gene Therapy Shows Promise for Patients with Pompe Disease
6. AAPM statement on quality radiation therapy
7. Congress Urged to Take Immediate Action to Ensure Frail Patients Continue to Receive Critical Therapy Services
8. Intensive Insulin Therapy Wont Boost Septic Shock Survival
9. News brief: Dermatologic infections in cancer patients treated with EGFRI therapy
10. A new target for lymphoma therapy
11. NCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
Post Your Comments:
(Date:11/25/2015)... ... ... “While riding the bus, I saw a passenger in a wheelchair drenched from ... a convenient and comfortable way to protect them from bad weather, so I invented ... during cold or inclement weather. In doing so, it ensures that the user remains ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
(Date:11/25/2015)... ... November 25, 2015 , ... An unlikely combination ... in a way for homeless people to have a more dignified and comfortable ... initiative whereby they are repurposing plastic bags into sleeping mats for the homeless. ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... focused on providing comprehensive solutions involving adult stem cell therapies to patients with ... deemed the “Regenestem” name as a Registered Trademark (RTM). , Organizations are required ...
(Date:11/24/2015)... ... 2015 , ... Genesis Chiropractic Software helps practice owners automate ... between the practice owner and the patient that automatically manages all five aspects ... Click here to learn more. , According to Dr. Brian ...
Breaking Medicine News(10 mins):
(Date:11/25/2015)... , November 25, 2015 Kitov ... ) (TASE: KTOV), a biopharmaceutical company focused on the ... various clinical conditions, today announced the closing of its ... Shares ( ADSs ), each representing 20 ordinary shares ... 3,158,900 ADSs. The ADSs and warrants were issued in ...
(Date:11/25/2015)... , Nov. 25, 2015 Allergan ... pharmaceutical company, and Rugen Therapeutics, a start-up  biotechnology ... for unmet CNS disorders and funded by the ... they have entered into an exclusive collaboration to ... for Autism Spectrum Disorders (ASD) and Obsessive Compulsive ...
(Date:11/25/2015)... Israel , November 25, 2015 ... "New Investors"), pursuant to which BioLight and the New ... IOPtima Ltd. subsidiary ("IOPtima") via a private placement. The ... of its innovative IOPtimate™ system used in the treatment ... approval pathway process for the IOPtimate™ system with the ...
Breaking Medicine Technology: